Asthma Guideline Implementation Classifying/Steps of Tx (Newman) Flashcards

1
Q

visit interval if asthma is not well controlled

A

2-6 week interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

visit interval if asthma is well controlled

A

3-6 month intervals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when to obtain subspecialist consult

A

0-4 years old and step 3 or higher (maybe step 2)

5 years or older and step 4 care

difficulty in achieving or maintaining asthma control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Step 1

A

SABA prn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Step 2

A

Low dose ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Step 3

A

0-4 yrs medium ICS + referral

> 5 yrs low dose ICS + LABA or
medium dose ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Step 4

A

MEdium dose ICS + LABA
or
montelukast + referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Step 5

A

high dose ICS + LABA
or
montelukast + referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Step 6

A

High dose ICS + LABA
or
Montelukast + OCS + referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Intermittent: Sx

A

<2 days/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Intermittent: Nighttime awakenings

A

0 (<4yrs)

<2xmo >5yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Intermittent: SABA use for symptoms

A

<2days/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intermittent: limitation of normal activity

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intermittent: lung function

A

FEV1>80%

FEV/FVC 85% (5-11) normal (>12yrs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intermittent: excerbation requiring OCS

A

0-1/year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intermittent: recommended step for therapy

17
Q

mild: Sx

A

> 2 days/week

18
Q

Mild: nighttime awakenins

A

1-2xmo (<4yr)

3-4xmo (>5 yr)

19
Q

mild: SABA use for symtoms

A

> 2days/week

20
Q

Mild: limitation of normal activity

21
Q

Mild: lung function

A

FEV1 >80%

FEV1/FVC >85% (5-11) normal (>12)

22
Q

Mild: exacerbations needing OCS

A

> 2/6mo (0-4yrs)

>2/year (>5yrs)

23
Q

Mild: recommended step for therapy

24
Q

Moderate: Sx

25
Moderate: Nighttime awakenings
3-4xmo (<4) | >1x/week (>5)
26
Moderate: SABA use for symptoms
daily
27
Moderate: Limitations of normal activity
some
28
Moderate: Lung Function
FEV1 >60% FEV1/FVC >75% (5-11) reduced by 5% (>12)
29
Moderate: Exacerbations requiring OCS
>2/6mo (0-4 yrs) | >2/year (>5 yrs)
30
Moderate: recommended step for initiating therapy
Step 3
31
Severe: Sx
throughout the day
32
Severe: Nighttime awakenings
>1x/week (<4) | 7x/week (>5)
33
Severe: SABA use for symptoms
several times a day
34
Severe: Limitation of normal activity
extreme
35
Severe: Lung function
FEV1 <60% FEV1/FVC <75% (5-11) reduced by >5% (>12)
36
Severe: Exacerbation requiring OCS
> 2/6mo (0-4 yrs) | >2/year (>5yrs)
37
Severe: Recommended step for initiating therapy
Step 3 (<4 yrs) Step 3 or 4 (5-11 yrs) Step 4 or 5 (>12 yrs)